Growth through STO Onpharma is partnering to launch the first Solana-based Security Token Offering, signaling a move into digital securities infrastructure. This creates opportunities to position the Onset EZ buffering pen as a regulated, compliant medical device compatible with modern private markets and investor-grade due diligence.

Dental buffering leadership With the Onset EZ buffering pen entering the market and emphasizing speed, simplicity and single-unit operatory deployment, there is a clear sales path to dental clinics and hospital dental departments seeking efficient, low-waste buffering solutions.

Digital channel ready Existing tech stack includes AdRoll, The Trade Desk, Shopify and Apple Pay, indicating readiness for targeted digital campaigns and direct-to-consumer or B2B ecommerce strategies to drive adoption of Onset EZ across dental markets.

Growing funding signals Revenue is in the low millions with a global market potential, and the recent strategic partnership around STOs suggests access to new capital and investor networks. This could enable expanded manufacturing capacity and broader distribution partnerships.

Strategic partnerships Collaborations with First Block and Crito Capital LLP position Onpharma to leverage fintech and capital markets expertise, enabling co-marketing, co-sponsorship of dental innovation events, and potential enterprise sales to clinics seeking advanced buffering technology.